<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">33966177</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>08</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>08</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2190-3948</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>12</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
            </PubDate>
          </JournalIssue>
          <Title>Drug delivery and translational research</Title>
          <ISOAbbreviation>Drug Deliv Transl Res</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Controlled release of pharmaceutical agents using eutectic modified gelatin.</ArticleTitle>
        <Pagination>
          <StartPage>1187</StartPage>
          <EndPage>1194</EndPage>
          <MedlinePgn>1187-1194</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s13346-021-00998-3</ELocationID>
        <Abstract>
          <AbstractText>Deep eutectic solvent (DES) is a class of ionic liquids, consisting of a mixture generally formed by combining hydrogen bond donors (HBDs) such as alcohols, amides and carboxylic acids with various quaternary ammonium salts. The decrease in melting points of the constituents is due to the charge delocalization during formation of hydrogen bonding between the hydrogen bond acceptor with the hydrogen bond donor. This can be considered one of the main reasons for increasing solubility and absorption of DESs. Most active pharmaceutical ingredients (APIs) have polar functional groups containing amide, carboxylic acid, alcohol or quaternary ammonium groups. These tend to increase the melting point of the compounds, but they can be used to form eutectic mixtures. While this concept has previously used, the combination of quaternary ammonium salts with amides, carboxylic acids and alcohols can result in large depressions of freezing points and so-called deep eutectic solvents are formed. DESs mix readily with water and so could increase the uptake of APIs. In this study, pharmaceutical deep eutectic solvents (PDESs) are formulated from 3 APIs: imipramine HCl, ascorbic acid and catechol. These PDESs were used to plasticise gelatine. It is shown that the materials formed can be used to increase the rate of API uptake via both oral and transdermal delivery modes. Thus, the concentration of the PDESs in solution reaches the maximum before the pure drugs. Particularly for catechol, after 1 s, the dissolution of the PDESs was more than twice that of the pure drug. Moreover, the transdermal delivery mode uptake of the PDES based on imipramine HCl from the patch after 15 min was found to be 65% compared with just imipramine HCl which released only 20%.</AbstractText>
          <CopyrightInformation>© 2021. The Author(s).</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Qu</LastName>
            <ForeName>Wanwan</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>School of Chemistry, University of Leicester, Leicester, LE1 7RH, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Qader</LastName>
            <ForeName>Idrees B</ForeName>
            <Initials>IB</Initials>
            <AffiliationInfo>
              <Affiliation>Pharmaceutical Chemistry Department, College of Pharmacy, Hawler Medical University, Erbil, Kurdistan Region, Iraq.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Abbott</LastName>
            <ForeName>Andrew P</ForeName>
            <Initials>AP</Initials>
            <Identifier Source="ORCID">0000-0001-9556-8341</Identifier>
            <AffiliationInfo>
              <Affiliation>School of Chemistry, University of Leicester, Leicester, LE1 7RH, UK. apa1@le.ac.uk.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>05</Month>
          <Day>08</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Drug Deliv Transl Res</MedlineTA>
        <NlmUniqueID>101540061</NlmUniqueID>
        <ISSNLinking>2190-393X</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000438">Alcohols</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000577">Amides</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D064751">Ammonium Compounds</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D002264">Carboxylic Acids</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D003692">Delayed-Action Preparations</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000644">Quaternary Ammonium Compounds</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D012492">Salts</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>9000-70-8</RegistryNumber>
          <NameOfSubstance UI="D005780">Gelatin</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>OGG85SX4E4</RegistryNumber>
          <NameOfSubstance UI="D007099">Imipramine</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000438" MajorTopicYN="N">Alcohols</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000577" MajorTopicYN="N">Amides</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D064751" MajorTopicYN="Y">Ammonium Compounds</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002264" MajorTopicYN="N">Carboxylic Acids</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003692" MajorTopicYN="N">Delayed-Action Preparations</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005780" MajorTopicYN="Y">Gelatin</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007099" MajorTopicYN="N">Imipramine</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000644" MajorTopicYN="N">Quaternary Ammonium Compounds</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012492" MajorTopicYN="N">Salts</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">And drug delivery</Keyword>
        <Keyword MajorTopicYN="Y">Deep eutectic solvents</Keyword>
        <Keyword MajorTopicYN="Y">Dissolution rate</Keyword>
        <Keyword MajorTopicYN="Y">Solubility</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>4</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>5</Month>
          <Day>10</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>9</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>5</Month>
          <Day>9</Day>
          <Hour>21</Hour>
          <Minute>3</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">33966177</ArticleId>
        <ArticleId IdType="pmc">PMC8942888</ArticleId>
        <ArticleId IdType="doi">10.1007/s13346-021-00998-3</ArticleId>
        <ArticleId IdType="pii">10.1007/s13346-021-00998-3</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Stott PW, Williams AC, Barry BW. J Control Release. 1998;50:297–308. doi: 10.1016/S0168-3659(97)00153-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0168-3659(97)00153-3</ArticleId>
            <ArticleId IdType="pubmed">9685897</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Benson HAEA. Curr Drug Deliv. 2005;2:23–33. doi: 10.2174/1567201052772915.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/1567201052772915</ArticleId>
            <ArticleId IdType="pubmed">16305405</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith EL, Abbott AP, Ryder KS. Am Chem Soc. 2014;114:11060–11082.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25300631</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abbott AP, Al-Murshedi AY, Alshammari OA, Harris RC, Kareem JH, Qader IB, Ryder K. Fluid Phase Equilib. 2017;448:99–104. doi: 10.1016/j.fluid.2017.05.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.fluid.2017.05.008</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vepuri SB, Anbazhagan S, Divya D, Padmini D. Indones J Pharm. 2013;131–150.</Citation>
        </Reference>
        <Reference>
          <Citation>Abbott AP, Ahmed EI, Prasad K, Qader IB, Ryder KS. Fluid Phase Equilib. 2017;448:2–8. doi: 10.1016/j.fluid.2017.05.009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.fluid.2017.05.009</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dean PM, Turanjanin J, Yoshizawa-Fujita M, MacFarlane DR, Scott JL. Cryst Growth Des. 2009;9:1137–1145. doi: 10.1021/cg8009496.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/cg8009496</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aroso IM, Silva JC, Mano F, Ferreira AS, Dionísio M, Sá-Nogueira I, Barreiros S, Reis RL, Paiva A, Duarte ARC. Eur J Pharm Biopharm. 2016;98:57–66. doi: 10.1016/j.ejpb.2015.11.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ejpb.2015.11.002</ArticleId>
            <ArticleId IdType="pubmed">26586342</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Santos LF, Correia IJ, Silva AS, Mano JF. Eur J Pharm Sci. 2018;118:49–66. doi: 10.1016/j.ejps.2018.03.020.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ejps.2018.03.020</ArticleId>
            <ArticleId IdType="pubmed">29572160</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pham TPT, Cho C-W, Yun Y-S. Water Res. 2010;44:352–372. doi: 10.1016/j.watres.2009.09.030.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.watres.2009.09.030</ArticleId>
            <ArticleId IdType="pubmed">19854462</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abbott AP, Abolibda TZ, Qu W, Wise WR, Wright LA. RSC Adv. 2017;7:7268–7273. doi: 10.1039/C7RA00135E.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1039/C7RA00135E</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qu W, Häkkinen R, Allen J, D’Agostino C, Abbott AP. Molecules. 2019;24:3583. doi: 10.3390/molecules24193583.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/molecules24193583</ArticleId>
            <ArticleId IdType="pmc">PMC6804121</ArticleId>
            <ArticleId IdType="pubmed">31590314</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Celebier M, Altinoz S. Die Pharmazie-An International Journal of Pharmaceutical Sciences. 2007;62:419–422.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17663188</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abbott AP, Capper G, Gray S. ChemPhysChem. 2006;7:803–806. doi: 10.1002/cphc.200500489.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/cphc.200500489</ArticleId>
            <ArticleId IdType="pubmed">16596609</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cai Y, Yu J, Kundu SC, Yao J. Mater Chem Phys. 2016;181:227–233. doi: 10.1016/j.matchemphys.2016.06.053.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.matchemphys.2016.06.053</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ruch RJ. Chem Expo Toxic Responses. 1996;1:33.</Citation>
        </Reference>
        <Reference>
          <Citation>Kilpatrick-Liverman L, Kazmi P, Wolff E, Polefka TG. Skin Research and Technology. 2006;12:162–169. doi: 10.1111/j.0909-752X.2006.00142.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.0909-752X.2006.00142.x</ArticleId>
            <ArticleId IdType="pubmed">16827690</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fluhr J, Darlenski R, Surber C. Br J Dermatol. 2008;159:23–34. doi: 10.1111/j.1365-2133.2008.08643.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2133.2008.08643.x</ArticleId>
            <ArticleId IdType="pubmed">18510666</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Touitou E, Junginger H, Weiner N, Nagai T, Mezei M. J Pharm Sci. 1994;83:1189–1203. doi: 10.1002/jps.2600830902.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jps.2600830902</ArticleId>
            <ArticleId IdType="pubmed">7830230</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>D’Agostino C, Gladden LF, Mantle MD, Abbott AP, Essa IA, Al-Murshedi AY, Harris RC. Phys Chem Chem Phys. 2015;17:15297–15304. doi: 10.1039/C5CP01493J.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1039/C5CP01493J</ArticleId>
            <ArticleId IdType="pubmed">25994171</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu D, Fei X, Wang S, Jiang T, Su D. Asian J Pharm Sci. 2006;1:213–221.</Citation>
        </Reference>
        <Reference>
          <Citation>Djagny KB, Wang Z, Xu S. Crit Rev Food Sci Nutr. 2001;41:481–492. doi: 10.1080/20014091091904.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/20014091091904</ArticleId>
            <ArticleId IdType="pubmed">11592686</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abbott AP, Alaysuy O, Antunes APM, Douglas AC, Guthrie-Strachan J, Wise WR. ACS Sustainable Chemistry &amp; Engineering. 2015;3:1241–1247. doi: 10.1021/acssuschemeng.5b00226.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/acssuschemeng.5b00226</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
